GlassScriptPhysician profile
Daniel N Pugliese
NPI 1255691549
$63,300.30
in general payments reported to CMS, 2019-2025
19 companies · $8,530 in 2025
The $8,530 reported for 2025 was more than what 77% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $458 · 2021: $39K · 2022: $5,872 · 2023: $4,898 · 2024: $4,074 · 2025: $8,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,875 · Food and Beverage: $5,740 · Consulting Fee: $3,700 · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,875.20 |
| Food and Beverage | $5,740.06 |
| Consulting Fee | $3,700.00 |
| Education | $187.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $41,942.28 | 2019-2025 | Aveir, Amplatzer Amulet, Jot Dx |
| Biotronik INC. | $12,223.22 | 2022-2025 | Acticor 7 Vr-T Dx, Rivacor 7 Dr-T, Edora 8 Dr-T |
| Medtronic, INC. | $3,340.23 | 2021-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Linq II |
| Boston Scientific Corporation | $2,743.10 | 2020-2025 | General - Therapies, Farapulse, Watchman Access System |
| Biosense Webster, INC. | $1,855.16 | 2021-2025 | Carto 3, Octaray Mapping Catheter, Nuvision Ice Catheter |
| E.R. Squibb & Sons, L.L.C. | $178.15 | 2022-2025 | Camzyos |
| Cardiva Medical, INC. | $177.86 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $164.62 | 2019-2022 | |
| Medtronic Vascular, INC. | $149.65 | 2019-2020 | |
| Abiomed | $143.69 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $85.74 | 2019-2025 | Wainua |
| Scpharmaceuticals INC. | $77.20 | 2025 | |
| Philips North America LLC | $67.16 | 2025 | Mcot |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.88 | 2025 | Jardiance |
| Altathera Pharmaceuticals LLC | $29.94 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $21.37 | 2025 | Attruby |
| Sanofi-Aventis U.S. LLC | $20.27 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.28 | 2025 | |
| Cordis US Corp. | $17.50 | 2025 | Mynx Control Venous |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Pugliese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.